FOXM1 and neoplasm: Collectively, our findings define FOXM1 as a master regulator of Rho-GTPase and stem cell marker expression and imply that reducing FOXM1 expression might be effective in blocking tumor progression in several critical ways: by decreasing the expression of mitosis-related genes, by reducing invasion potential and by diminishing the proportion of CSCs, thereby enhancing sensitivity to cancer therapeutic agents.